An initiative by Invest Sweden and Swedish Trade Council - in collaboration with Swedish Medtech, Swecare and Sweden Bio

Take the opportunity to get your company matched with major European VC investors

• A selected group/platform of some of the most interesting Life Science investors in Switzerland and Europe with interest in Swedish Life Science companies
  
• Novartis Venture Funds is one of the world’s largest corporate biotech venture funds managing MUSD 750
• HBM Partners is among the global leaders in Life Science-focused investing with USD 1 billion under managemen
• Red Alpine is active in early stage venture capital fund investing in Life Science and ICT with focus on e.g. Scandinavia
• BBBiotechVentures is a healthcare dedicated venture capital fund in the Bellevue Group (listed on the SIX Swiss Exchange)
  
• Access to key decision makers and dedicated feedback on your company
• Opportunity to get short listed for in-depth discussions with venture capital funds

What are the Swiss investors looking for?

• Drug development, biotech platforms, medtech/medical device, diagnostics, therapeutics
• From start-up/seed capital to late stage investments
  
• From R&D, clinical studies and human proof-of-concept trials to registration trials/marketing and businesses/growth capital
  
• Investment range MEUR 0.1-30
• Innovative and leading companies in their niche

How do I participate?
Register no later than July 14th trough the form below (click on the link "Anmäl dig") and you will be contacted by Invest Sweden or the Swedish Trade Council with further information.

Why Swiss Venture Capital? - Switzerland constitutes an interesting VC  pool

• Even in the current down turn Swiss VC investments in Life Science show steady volumes and actually increases relative other segments
• The VCs see a problem in the low “deal flow” i.e. a lack of interesting business ventures
• The Swiss VCs invest 90% of their capital (that is to a  relative high degree foreign capital) in European ventures
  
• Historically, however investments in Swedish entities have not been substantial

If you have any questions please contact:

Hampus Nilzén 
Hampus.nilzen@swedishtrade.se
+43 1 402 35 15 21

Peter Bramberg
peter.bramberg@investsweden.se
+46  8 402 78 45